Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Respiratory tract diseases
MeSH D012140 - respiratory tract diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D012140:
Â
Respiratory tract diseases
50 Companies
6 Drugs
$
Success rate
D001982:
Bronchial diseases
0 Companies
0 Drugs
Success rate
D002925:
Ciliary motility disorders
0 Companies
0 Drugs
Success rate
D007818:
Laryngeal diseases
0 Companies
0 Drugs
Success rate
D008171:
Lung diseases
3 Companies
2 Drugs
$
Success rate
D009668:
Nose diseases
0 Companies
0 Drugs
Success rate
D010995:
Pleural diseases
0 Companies
0 Drugs
Success rate
D012120:
Respiration disorders
50 Companies
9 Drugs
$
Success rate
D012130:
Respiratory hypersensitivity
3 Companies
1 Drug
$
Success rate
D012141:
Respiratory tract infections
97 Companies
34 Drugs
$
Success rate
D012142:
Respiratory tract neoplasms
0 Companies
0 Drugs
Success rate
D013896:
Thoracic diseases
0 Companies
0 Drugs
Success rate
D014133:
Tracheal diseases
0 Companies
0 Drugs
Success rate
D015619:
Respiratory system abnormalities
0 Companies
0 Drugs
Success rate
D015769:
Respiratory tract granuloma
0 Companies
0 Drugs
Success rate
D016156:
Respiratory tract fistula
17 Companies
3 Drugs
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
AstraZeneca
Budesonide
,
Formoterol
,
Glycopyrrolate
Â
Breztri AerosphereÂ
2030-05-28Â
2020-07-23Â
Â
Â
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
100
%
7/7
Phase 2
37
%
7/19
Phase 3
8
%
2/25
Approved:
2
Overall Success rate:
3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Roche
Pirfenidone
,
Transplatin
,
Albumin
,
Antithrombin iii
,
Retinol
AstraZeneca
Budesonide
,
Formoterol
,
Formoterol fumarate dihydrate
,
Glycopyrrolate
Novartis
Glycopyrrolate
,
Indacaterol
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use